Navigation Links
BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
Date:4/14/2009

Toronto Stock Exchange Symbol: MS

EDMONTON, April 14 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's U.S. pivotal phase III MAESTRO-03 trial of dirucotide in patients with secondary progressive MS has completed a safety analysis and recommended that the trial continue as per the protocol.

This was the fourth of several regularly scheduled reviews by the DSMB that will occur over the duration of the trial. The purpose of the DSMB is to provide objective, independent safety monitoring of the trial.

    About MAESTRO-03
    ----------------

The MAESTRO-03 U.S. pivotal phase III clinical trial is a randomized, double-blind study that has completed recruitment of approximately 510 patients at 67 clinical sites who will be administered either dirucotide or placebo intravenously every six months for a period of two years. The primary clinical endpoint for the trial is defined as a statistically and clinically significant increase in the time to progression of the disease as measured by the Expanded Disability Status Scale (EDSS), in patients with HLA-DR2 and/or HLA-DR4 immune response genes (up to 70% of all MS patients are HLA-DR2 and/or HLA-DR4 positive).

    About BioMS Medical Corp.
    -------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for Secondary Progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Compan
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical Announces 2008 Year End Results
2. BioMS Medical warrant extension
3. BioMS Medical to present at BIO CEO and Investor Conference
4. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
5. BioMS Medical recognized at Scrip Awards 2008
6. BioMS Medical Announces Third Quarter 2008 Results
7. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
8. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
11. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: ... to take charge of their health at home through the ... dividend of $3.00 per share on its Series B Convertible ... in shares of Series B stock in an amount per ...
(Date:12/2/2009)... MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging ... the planet. Through the efforts of True Green Energy Group ... who has been in the recycling business for over 25 ... of everyone and is setting the stage for spectacular earnings ...
(Date:12/2/2009)... Nearly 600 medical research executives, scientists, policy makers, ... and innovative funding strategies at the inaugural Partnering ... the Washington-based center of the Milken Institute, convened ... to turn a scientific discovery into an accessible therapy. ...
(Date:12/2/2009)... , - "Bolstering Biodiversity ... Coinciding with the International Year ... hosting an international conference in Libreville,(Gabon) on the ... will be attended by government and state leaders, ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2
... Emisphere,Technologies, Inc. (Nasdaq: EMIS ), announced ... on Thursday, May 8, 2008, at the Westin,Governor ... Jersey. The,meeting will begin at 10:00 a.m. EDT., ... Inc. is a biopharmaceutical company that,focuses on a ...
... WallSt.net,s 3-Minute Press Show is,a daily video ... Shows air Monday through Friday on:, ... in-depth interviews with,public company executives on their company ... to provide viewers with insight into a company,s ...
... researchers at ... with internal solutions, REDWOOD CITY, Calif., April 15 ... life science researchers, and,Pfizer Pharmaceuticals, Inc. (NYSE: PFE ... a strategic,partnership today. This new multi-year partnership promotes enterprise-wide,deployment ...
Other Biology Technology:Emisphere Technologies To Hold Annual Stockholders Meeting on May 8, 2008 2Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR 2Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: NPHC, PECD, PNRR 3Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 2Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis 3
(Date:12/3/2009)... and animal species can be likened to emptying a museum ... medicines into the trash, or replacing every local cuisine with ... habitats may not just make the world boring. New research ... for catching some nasty disease. , "Habitat destruction and biodiversity ...
(Date:12/3/2009)... CTRC-AACR San Antonio Breast Cancer Symposium continues to attract ... from industry and academia with the goal of eradicating ... scientists and other professionals will gather at the Henry ... 9-13, 2009. The symposium is a partnership between the ...
(Date:12/3/2009)... a personality change in warmer water, according to an intriguing ... more aggressive. , Experiments with two species of young damselfish ... time that some reef fish are either consistently timid, or ... marked as water temperatures rise. , A slight lift of ...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 1USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 2USC Hospitals Extend Relationship With Quantros to Manage Compliance and Risk 13010 3Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 1Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 2Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 51584 3Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 1Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 2Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 3Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 4Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 5Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 6Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 7Brain Imaging 28MRI PET 29 and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis 51579 8
... young, apparently healthy athletes suddenly collapse, it can be due ... have now discovered a genetic modification that leads to cardiac ... can give zebrafish a heart condition. Since the fish have ... could be critical for humans as well. , ...
... Research(R), a revolutionary biometric media research firm specializing ... of Andre Marquis as Senior Vice President of ... for expanding Innerscope,s offering into the growing digital ... innovative digital initiatives for start-ups and Fortune 500 ...
... are being recruited to get outdoors and help track ... and animal behavior. , The USA-National Phenology Network (USA-NPN), ... a new national program built on volunteer observations of ... and resource managers will use these observations to track ...
Other Biology News:Why 'lazy Susan' has a weak heart 2Innerscope Research(R) Appoints Digital Leader, Andre Marquis, as Senior Vice President of Sales and Marketing 2Taking the pulse of our planet 2
Human PDGF R beta MAb (Clone # PR7212)...
Rabbit Serum New Zealand or California Origin...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
...
Biology Products: